產(chǎn)品名稱(chēng)：DMS79人小細(xì)胞肺癌細(xì)胞、DMS79人小細(xì)胞肺癌細(xì)胞、DMS79人小細(xì)胞肺癌細(xì)胞、DMS79人小細(xì)胞肺癌細(xì)胞；

emphasis is on tumor-infiltrating DCs. We address how they affect tumor growth and expansion, and we highlight innovative approaches for therapeutic modulation of these immunosuppressive DCs which is necessary for future personalized therapeutic approaches.In the past decade, we have witnessed the revolution in cancer therapy, especially in the rapid development of cancer immunotherapy. In particular, the introduction of